ConductScience.org, home

Comparison · NCT00358579-85557135

Adrenaline vs Vasopressin: Return of Spontaneous Circulation.

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Adrenaline vs Vasopressin: Return of Spontaneous Circulation. Trial comparisons, record NCT00358579-85557135. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00358579-85557135

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.30.2550.35wilson
Risk in group 20.3180.2730.367wilson
Risk difference, group 1 minus group 2-0.0179-0.08460.0493newcombe hybrid score
Risk ratio, group 1 over group 20.9440.7591.17log
Odds ratio, group 1 over group 20.920.6711.26log
Number needed to treat, for one fewer participant with the outcome on Adrenaline than on Vasopressin55.9from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Adrenaline1 mg Intravenous Adrenaline, administered as the first drug upon cardiac arrest patient's arrival at the Emergency Department106353OG000
Group 2Vasopressin40 IU Intravenous Vasopressin, administered as the first drug upon cardiac arrest patient's arrival at the Emergency Department119374OG001

Outcome

Type
SECONDARY
Title
Return of Spontaneous Circulation.
Description
Return of spontaneous circulation is defined as the presence of any palpable pulse detected by manual palpation of a major artery. This is measured as number of participants who had return of spontaneous circulation during resuscitation.
Time frame
during resuscitation
Population

Source ClinicalTrials.gov

Trial

Title
Comparing Vasopressin and Adrenaline in Patients With Cardiac Arrest
NCT number
NCT00358579
Phases
PHASE3
Conditions
Cardiac Arrest
Interventions
Adrenaline, Vasopressin
Lead sponsor
Singapore General Hospital
Results first posted
2011-08-09

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00358579-85557135